ROBIN NIEDERWERFER: Open Payments
NPI 1871781450 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 115 payments from 14 companies in 2025. Trend: 2023 $1,119 · 2024 $1,432 · 2025 $1,714
Food & beverage: $1,714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $416 |
| Janssen Biotech, Inc. | 22 | $352 |
| Ardelyx, Inc. | 11 | $189 |
| Lilly USA, LLC | 12 | $184 |
| Madrigal Pharmaceuticals | 7 | $131 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 10 | $54 |
| Novo Nordisk Inc | 3 | $51 |
Products named: TREMFYA, RINVOQ, IBSRELA, OMVOH, REZDIFFRA, CREON, ZENPEP, ENTYVIO.
Industry payments across SC — which companies pay providers there.
